NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission, Genomic Health reported a $3.2 million realized gain in 2016 from a sale of equity securities in connection with the sale of a portion of its Invitae stock holdings. The company further sold all its remaining shares in Invitae in January 2017 for $10.2 million, resulting in a realized gain of $2.8 million.
Argonaut Manufacturing Services, a contract manufacturing organization for the life science and molecular diagnostics markets, announced that it has received ISO 13485:2016 certification from the British Standards Institute.
The company also said this week that it has received a $5 million credit facility from Pacific Western Bank division Square 1 Bank. Argonaut will use the proceeds to support capital expenditures associated with its recent expansion.
In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on the GenomeWeb site.